Remedium Capital Partners, LLC
6 holdingsFiling period: 2026-06-30Current AUM: $428.2Mestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | ORKA | Oruka Therapeutics Inc | 1.57M | $149.0M | $141.4M | 33.03% | -323,454 | 2026-06-30 |
| 2 | SYRE | Spyre Therapeutics Inc | 1.46M | $130.0M | $136.0M | 31.77% | -443,158 | 2026-06-30 |
| 3 | APGE | Apogee Therapeutics Inc | 586.7K | $77.9M | $77.9M | 18.19% | +3.1K | 2026-06-30 |
| 4 | DMRA | Damora Therapeutics Inc | 2.05M | $53.2M | $43.5M | 10.16% | -- | 2026-06-30 |
| 5 | JBIO | Jade Biosciences Inc | 1.58M | $35.1M | $22.9M | 5.34% | -- | 2026-06-30 |
| 6 | — | Crescent Biopharma Inc | 361.3K | $6.5M | $6.5M | 1.52% | -- | 2026-06-30 |
← Scroll →